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Objectives: There is increasing evidence that physical activity (PA) can affect health out-
comes, particularly in chronic disease. While pharmacologic therapy and exercise training
can improve exercise capacity, increasing PA requires behavior change. This review examined
clinical trials testing the effectiveness of behavioral interventions to increase PA in adults with
chronic disease to inform future research in COPD.
Methods: Embase and PubMed searches of studies published in English, 1995e2011. Inclusion
criteria: Adults 45 years; COPD, diabetes, heart failure, obesity; exercise or PA endpoint;
behavioral intervention described in sufficient detail to permit interpretation.
Results: 932 abstracts screened; 169 articles retrieved; 36 reviewed. Most were randomized
trials (n Z 32, 89%); 2 arms (n Z 26, 72%), sample sizes 40e100 (n Z 15, 42%); recruitment
through clinical settings (n Z 28, 78%); disease severity as primary eligibility criterion
(nZ 23, 64%); mean duration: 10 months (range: 1e84). Exercise intervention: aerobic activ-
ity, 30e60 min (n Z 20, 56%), 3e5 times/week (n Z 20, 56%). Behavioral intervention: Coun-
seling (n Z 19, 53%) with personal follow-up (n Z 12, 33%). Control group: Exercise without
behavioral intervention (nZ 14, 39%) or usual care (nZ 15, 42%). Significant effects were re-
ported in 15 of 25 (60%) studies testing exercise capacity (6-minute walk, cycle, treadmill), 19
of 26 (73%) testing PA (pedometer, activity log, questionnaire), 11 of 22 (50%) measuring qual-
ity of life, and 8 of 13 (62%) capturing behavioral endpoints.1 664 7272; fax: þ1 301 654 9864.
ra.com (N.K. Leidy).
3 Elsevier Ltd. All rights reserved.
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Designing activity trials for COPD 473Conclusions: This review provides insight into the range of designs, interventions, and outcome
measures used in studies testing methods to improve PA in chronic disease with implications for
designing trials in COPD.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a chronic
respiratory disease characterized by a decline in lung func-
tion over time and accompanied by respiratory symptoms,
primarily dyspnea, cough, and sputum production. Despite
considerable advances in the management of the disease
over the past 3 decades, COPD continues to be a growing
cause of morbidity, mortality, and health-care costs world-
wide [1,2]. Dyspnea is a major cause of reduced exercise
capacity [3,4] and can lead to limitations in physical activity
(PA) [5], i.e., movement resulting in elevated energy
expenditure beyond basal levels, including standing or
walking performed as part of one’s daily activities.
It is widely recognized that a program of regular exercise
can improve health, with increasing attention given to the
effect of PA levels on health outcomes, particularly in
people with chronic disease. Research suggests that higher
levels of PA may prevent or delay the onset or progression
of a range of chronic diseases and improve quality of life
[6e10] and that sedentary behavior (low levels of PA) is an
independent risk factor of poor health outcomes [11e13].
There is also evidence to suggest that PA levels in people
with COPD are lower than healthy controls and patients
with other chronic diseases [6,14] and that this inactivity
may contribute to a downward spiral of deconditioning,
increased dyspnea, exacerbations, declining lung function,
and mortality [14e16]. Conversely, improving activity may
improve health and well-being in people with COPD
[17e20]. Although pharmacologic therapy and exercise
training can improve the patient’s capacity to increase
activity, consistently and persistently increasing and
maintaining PA requires a change in health behavior.
It has been proposed that interventions to change
behavior are more effective when guided by an appropriate
theoretical framework that fits the health problem of in-
terest [21]. Four commonly-used theories of health
behavior are the Health Belief Model (HBM) [22], Social
Cognitive Theory (SCT) [23], Theory of Reasoned Action and
Planned Behavior [24], and the Trans-theoretical (Stages of
Change) Model (TTM) [25]. The HBM postulates that health
behavior is predicted by one’s belief or perceptibility of
acquiring a disease and the approaches available to
decrease the likelihood of occurrence [22]. SCT explains
how individuals acquire and maintain specific behavioral
patterns through observation [23]. The Theory of Reasoned
Action and Planned Behavior proposes that a person’s
behavior is ultimately determined by their intent to
perform the behavior, where intention is a function of at-
titudes and beliefs toward the behavior, the subjective
norms, and perceived control behaviors [24]. Finally, the
TTM conceptualizes a series of steps individuals move
through in order to reach a specified behavior change. Thismodel describes behavior change as a process in which
intrinsic rewards or incentives are built to maintain positive
health outcomes [25]. Across these theories, social support
performs a vital role in understanding health behaviors and
facilitating change, particularly in relationship to personal
activity and exercise programs. Intervention studies
informed by an underlying model or theoretical framework
for understanding inactivity or a sedentary lifestyles and
creating corresponding, targeted interventions to improve
activity levels should be more likely to detect significant
and meaningful treatment effects.
The purpose of this literature review was to examine
clinical intervention studies testing behavioral in-
terventions designed to increase PA in patients with chronic
disease. Specifically, the intent was to identify key ele-
ments of studies that successfully improved activity levels,
including sample selection and size, exercise and behav-
ioral interventions, and outcome measures, to inform
future studies in people with COPD.Methods
A broad range of candidate articles were identified through
Embase and PubMed using the following search terms:
“physical activity”, “motor activity”, “exercise”, “exercise
prescription”, “physical fitness”, “sedentary lifestyle”,
“behavior modification”, “health behavior”, “health pro-
motion”, “behavioral intervention”, “intervention
studies”, “program evaluation”, and “clinical trial”. The
search was limited to empirical studies conducted in adults
45 years of age and published in English from 1995 to
2011. Abstracts were reviewed and selected for further
evaluation if a behavioral intervention was tested in a
sample of patients with COPD, diabetes, congestive heart
failure or obesity, and exercise capacity, or PA was speci-
fied as a trial endpoint. The alternative chronic conditions
were selected based on a common feature of inactivity with
adverse health consequences and the potential for testing
successful behavioral interventions in studies of patients
with COPD. Although exercise capacity and PA are different
health outcomes, with improvements in one not necessarily
associated with improvements in the other, studies with
either outcome were permitted to broaden the base of
candidate exercise and behavioral interventions. Articles
identified as potentially relevant were retrieved and
reviewed, with papers excluded based on the following
criteria: No outcome measure specified for PA or exercise
capacity; limited description of the behavioral interven-
tion, precluding further development or replication; or
small sample size (n  10). Because the focus was on in-
terventions to increase PA outside of a rehabilitation pro-
gram, rehabilitation trials were excluded.
Table 1 Key study design characteristics.a
Study characteristic Frequency
of studies
reviewed
(N Z 36)
Foundation
Based on theoretical modelb 26 72%
Design
Randomized controlled trial 32 89%
2 treatment arms 26 72%
3e4 treatment arms 6 17%
Control group intervention
Exercise without behavior modification 14 39%
Usual care 9 25%
Continue usual activities 4 11%
Stretching 2 6%
Non-RCT designs
Pre-testepost-test design 2 6%
Prospective controlled 2 6%
Subject recruitment
474 N.K. Leidy et al.Articles selected for inclusion were reviewed for quality
across 5 dimensions: Clarity and comprehensiveness of the
background information, including use of a theoretical
model; description of the intervention, such as staffing,
training, and information provided to subjects, types of
movement or exercises, and materials or equipment; study
design, including sample selection, size, and randomiza-
tion; targeted outcome measures for exercise capacity, PA,
and health outcomes; and magnitude of the treatment ef-
fect, including statistical significance, effect size, and
clinical meaning. Each dimension was rated on a 4-point
scale, from 1 (poor) to 4 (excellent) which was summed to
yield an overall quality score (5e20). Papers with scores
10 were considered poor, >10 to <15 of moderate quality,
and 15 of high quality.
To facilitate synthesis, articles were summarized in a
data extraction table with the following categories: Trial
objective, study and population characteristics, methods,
results, and study limitations. Key study characteristics
were summarized in an Excel spreadsheet for
interpretation.Clinical setting 28 78%
Media 5 14%
Sample
Sample size
50 16 44%
50e100 10 28%
100e200 7 19%
300 3 8%
Diagnosis
COPD 13 36%
Diabetes 11 31%
Heart failure 9 25%
Obesity 3 8%
Trial duration
2 months 5 14%
3 months 13 36%
4e6 months 4 11%
12 months 14 39%
COPD Z chronic obstructive pulmonary disease;
RCT Z randomized controlled trials.
a Key findings only; not all categories presented.
b Trans-theoretical (Stages of Change) Model [24], Social
Cognitive Theory [22], Health Belief Model [21].Results
Of the 932 abstracts identified in the Embase and PubMed
search and review, 169 (18%) met the initial screening
criteria and were retrieved for full text review. Thirty-six
papers (21% of 169) met the next level screening re-
quirements and were selected for quality review, data
abstraction, and synthesis [19,26e60]. Quality ratings for
these 36 papers ranged from 9 to 20, with 2 (6%) rated poor,
21 (58%) moderate, and 13 (36%) receiving a high quality
rating.
Study designs
Key study design characteristics across the 36 reviewed
studies are summarized in Table 1. Most studies were ran-
domized controlled trials (RCTs) with 2 treatment arms.
Participant recruitment was primarily through clinical set-
tings, such as hospitals or clinics. Mean study duration was
10 months, with a range of 1e84 months. Most studies used
disease severity as an eligibility criterion (nZ 23, 64%); 11
studies (31%) enrolled participants based on PA limitation.
Interventions
Exercise and behavior modification interventions are sum-
marized in Tables 2 and 3, respectively. The exercise
component of the interventions generally included some
form of aerobic activity, performed for 30e60 min per
session, 3e5 times per week. Most of the trials included
“walking” as either the sole exercise or as a choice among
other aerobic activities. Nearly one-third of the trials also
included muscle strength training. The majority of the
studies provided subjects with exercise instruction or
training individually. Initially, the exercise sessions were
supervised and performed in a facility, such as a medical
center, followed by unsupervised exercise at home for the
remainder of the trial.The behavioral interventions (Table 3) included educa-
tional programs, counseling, support, and/or some form of
contact designed to improve knowledge, motivation, self-
efficacy, and/or social support. Interventions that pro-
vided educational programs incorporated this information
into individualized or tailored exercise programs. Exercise
programs included Nordic walking [28], monthly physical
therapy group sessions [30], treadmill exercise sessions [32],
and personalized exercise programs [55,58]. Counseling in-
terventions included combined dieting and PA counseling
[33,43], motivation to continue positive behavioral activity
[42,45e47], and sessions to address any concerns or answer
questions [40]. Two forms of support were offered: provision
of equipment and social support. Equipment provided to
participants included heart rate monitors [39,45], free
weights [53], and pedometers [60]. Social support consisted
Table 2 Exercise interventions.a
Exercise Frequency
of studies
reviewed
(N Z 36)
Typeb
Walking 23 64%
Muscle strength training 11 31%
Exercise or aerobic activity (not
specified)
8 22%
Biking 7 19%
Other (stairs, running,
calisthenics)
6 17%
Duration per sessionc
<30 min 1 3%
30 min 12 33%
30e60 min 8 22%
>60 min 1 3%
Not reported 14 39%
Sessions per weekc
1e2 times 7 19%
3 times 11 31%
4e5 times 9 25%
Not reported 6 17%
Alone or groups
Alone 25 69%
Groups 4 11%
Both 4 11%
Not reported 3 8%
Setting
Facility-supervised then
Home-unsupervised
15 42%
Facility-supervised 9 25%
Facility-unsupervised 1 3%
Home-unsupervised 7 19%
Home-unsupervised then
Facility-supervised
2 6%
Not reported 2 6%
a Key findings only; not all categories presented.
b Some studies offered more than 1 exercise type.
c For studies reporting ranges, the highest value was used.
Table 3 Behavioral interventions.a
Intervention
components
Frequency of studies reviewed
(N Z 36)
Intervention
group
Control
group
Second
intervention
group
Education
Individualized
training
16 (44%) 2 (6%) 4 (11%)
Information
dissemination/
program
8 (22%) 6 (17%) 1 (3%)
Counseling 19 (53%) 3 (9%)
General 10 (28%) 4 (11%) 1 (3%)
Motivational 9 (25%) 0 (0%) 2 (6%)
Support
Social 5 (14%) 0 (0%) 0 (0%)
Equipment 6 (17%) 1 (3%) 0 (0%)
Contact e follow-up
Personal e nurse or
physical therapist
12 (33%) 9 (25%) 4 (11%)
Print 2 (6%) 2 (6%) 0 (0%)
a Key findings only; not all categories presented.
Designing activity trials for COPD 475of phone coaching and exercise support groups [54,57,58].
Personal contact, as a means of support, included video
conferences with educators [60], phone calls and visits with
physiotherapists and dieticians [43], and text messaging
with nurses [55]. Non-personal, print materials included
exercise booklets [39] and websites with interactive fea-
tures such as message boards and PA logs [50].
Interventions provided to the control group included
standard or usual care (either not described or described as
general recommendations to participate in exercise)
(n Z 9), instructions to continue usual activity (n Z 4,
11%), stretching exercises (n Z 2, 6%), or an exercise
intervention with no behavioral intervention (nZ 14, 39%).
Outcomes
Study outcomes could be classified into 4 categories:
Physical capacity, PA, behavioral, and health-relatedquality of life (HRQL). Physical capacity measures
included any type of exercise tolerance testing, such as the
6-minute walk distance (6MWD), cycle ergometry, and
treadmill testing. PA measures documented levels of daily
activity and were further classified as objective, including
pedometer and accelerometer, or patient-reported
outcome (PRO) measures, such as an activity log or ques-
tionnaire. Behavioral outcomes included PRO measures of
self-efficacy and social support. Finally, HRQL outcomes
were generic or condition-specific PRO instruments assess-
ing multiple dimensions of physical and mental health,
including the Medical Outcomes Study 36-Item Short-Form
Health Survey (SF-36), Quality of Well Being Scale, and the
St. George’s Respiratory Questionnaire (SGRQ), among
others.
The number of studies with at least 1 of these outcome
categories and the frequency of significant between-group
treatment effects is shown in Fig. 1. Most of the studies
testing treatment effects on PA (19 of 26, 73%) reported
statistically significant between-group differences, and
more than half (60%) of those evaluating physical capacity
as an endpoint reported significant treatment effects.
Eighteen studies measured both capacity and activity, with
3 of these reporting statistically significant between-group
differences in both endpoints (P  0.05)
[19,26e31,35e39,45,48,49,51,54e57]. Two of these studies
targeted patients with COPD (n Z 65 [28]; n Z 159 [37])
and 1 involved patients with obesity (n Z 173 [45]).Characteristics of trials showing significant
improvements in physical activity (PA)
Key features of the 19 trials reporting significant PA out-
comes are summarized in Table 4. Most (15 of 19, 79%) were
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Figure 1 Frequency of measurement and statistically significant effects by outcome type.
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of 19, 53%). The majority were RCTs with 2 study arms and
subject recruitment through a clinical site, using either
disease severity or activity limitation as inclusion criterion.
All studies enrolled fewer than 100 participants, with half
enrolling 50 or fewer. The exercise intervention included
walking or other modes of exercise, generally 30 min per
session, 3e5 times per week, performed independently,
and complimented with one or more behavioral in-
terventions such as counseling, personal contact (i.e.,
email or telephone communication) or educational pam-
phlets. Most of these trials used individual instruction or
training. Study duration ranged from 3 to 12 months.
Five (26%) of the trials showing significant effects on PA
also reported significant between-group differences in
physical capacity. Each of the 5 studies of patients with
COPD reported between-group differences in PA
[19,28,37,51,55], with 3 of the studies also reporting sta-
tistically significant HRQL effects [19,28,51]. Of the 2 COPD
trials showing no statistically significant HRQL effects, 1
had a sample size of 17 [55] and the other had a sample size
of 159 [37].
COPD-specific results
Five of the 8 studies of COPD evaluating PA outcomes
showed significant treatment effects for this endpoint
[19,28,37,51,55] (Table 5). Descriptively, these trials were
based on a theoretical model (3 of 5) and tested individu-
alized training (3 of 5) with education (4 of 5) and personal
contact (3 of 5), while control groups received education
and contact via print materials. The intervention group
participated in individual exercise training (3 of 5), such as
walking (including Nordic walking) at least 3 times per week
for 30e45 min. One study based exercise intensity on
baseline maximum heart rate [28]. Control groups received
standard of care with no exercise program. PA was
measured objectively using an accelerometer or pedom-
eter, while physical capacity was evaluated using the
6MWD, cycle ergometry, or the shuttle walk test.Discussion
There is evidence to suggest that manymen and womenwith
COPD live a sedentary lifestyle that may be harmful to their
health. The purpose of this literature review was to examine
clinical intervention studies testing behavioral interventions
designed to increase PA in patients with chronic disease to
inform future studies of people with COPD.
Results suggest that successful trials of behavioral in-
terventions to improve PA in people with a chronic illness
were informed by a theoretical model of health beliefs or
stages of readiness, and tested interventions that included
some element of individualized treatment, with or without
a formal exercise regimen. The behavioral interventions
were designed to address the participant’s unique in-
terests, concerns, or needs related to PA and included some
form of motivational counseling or program to provide
positive reinforcement, enhance self-efficacy, offer social
support, and encourage the adoption of the target health
behavior, i.e., increased PA. The initial intervention often
took place in a group setting, with a home program to
complement or extend the group sessions. Phone coaching
or motivational calls, notes, texts, or other forms of con-
tact and simple equipment such as pedometers, were used
to provide support and encourage persistence.
The most commonly tested exercise intervention was
walking, either as a primary exercise modality or, more
commonly, as one of several exercise activities selected by
participants during the individualized intervention process.
Walking is a common and necessary activity in daily life that is
often associatedwith breathlessness in patientswith COPD. It
is also a behavior that can be easily quantified in terms of
number of steps (via pedometer) or time spent walking,
standing, or engaging in moderate intensity activity (via
actigraph). Adherence to a walking program can also be
monitored and reinforced through self-monitoring pedometer
steps [61] and/or a daily participant-completed activity log.
The capacity to walk, including the ability of patients to
pace themselves and increase their walking distance with
treatment, can be captured through the 6MWD or shuttle
Table 4 Key features of trials showing significant im-
provements in physical activity (PA).a
Study characteristic Frequency
of studies
showing
improvement in PA (N Z 19)
Foundation
Based on theoretical modelb 15 79%
Design
Randomized controlled trial 17 89%
2 treatment arms 14 74%
Active treatment intervention
Exercisec:
Walking 12 63%
30 min per session 9 47%
3e5 times/week 9 47%
Behavioral intervention:
Individualized training 9 47%
Counseling-general or motivational 12 63%
Education-program 4 21%
Contact-personal 10 53%
Social support 4 21%
Education-print 4 21%
Contact-print 4 21%
Control group intervention
Exercise:
Same exercise without behavioral
modification
9 47%
Usual care, activities, or stretching 9 47%
Behavioral intervention:
Individualized training 0 0%
Counseling-general or motivational 3 16%
Education-program 2 11%
Contact-personal 4 21%
Social support 0 0%
Education-print 3 16%
Contact-print 2 11%
Subject recruitment
Clinical setting 14 74%
Media 3 16%
Sample
Sample size
50 7 37%
50e100 7 37%
Inclusion criteria
Disease severity 10 53%
PA limitation 9 47%
Trial duration
3 months 7 37%
12 months 6 32%
COPD-specific studies 5 26%
Significant effect on PA 5 26%
Significant effect on HRQL 3 16%
COPD Z chronic obstructive pulmonary disease;
HRQL Z health-related quality of life; PA Z physical activity;
RCT Z randomized controlled trials.
a Key findings only; not all categories presented.
b Trans-theoretical (Stages of Change) Model [25], Social
Cognitive Theory [23], Health Belief Model [22].
c Some studies offered more than 1 exercise type.
Designing activity trials for COPD 477walk test. Walking speed is not only directly related to the
intervention, but is meaningful and interpretable as an in-
dicator of health status [62,63] and predictor of future
health outcomes [64]. Because dyspnea is a rate-limiting
factor in COPD and reducing dyspnea is an important goal
of treatment, the Borg dyspnea scale can be used to cap-
ture breathlessness during the 6MWD test [65], with out-
comes expressed in terms of dyspnea level per distance
walked.
PA outcomes can be measured in terms of the amount
and type of movement actually performed, recorded in an
activity monitor, diary or survey, and the difficulty or ease
with which people perform their daily activities. These
types of activity outcomes provide different, complemen-
tary information on the effects of treatment [66,67].
Perception of ease or difficulty performing activities can be
tested using PRO instruments, such as the SF-36 Physical
Function and Role Physical or Physical Component Scores
(PCS). A condition-specific measure, such as the Functional
Performance Inventory-Short Form (FPI-SF), may be even
more sensitive to treatment effects [68].
Two RCTs of COPD showed significant effects on both
exercise tolerance and PA [28,37]. In each case, the intent
was to test the combined effect of exercise and behavioral
intervention on these outcomes, without isolating their
independent effects. This assumes or permits indirect
behavioral effects associated with an exercise program,
such as social support or trainer encouragement, to
interact or complement the explicit behavioral in-
tervention(s) to improve the 2 health outcomes. Under this
model, the entire package of care (i.e., exercise with
behavioral interventions) serves as the intervention to
improve physical capacity and PA. In both RCTs, the inter-
vention was successful in achieving this goal.
Based on the insights provided in the literature, in-
vestigators interested in conducting a clinical trial testing
interventions to improve PA in patients with COPD might
consider the following design elements.
 Study Design
B Randomized controlled trial
B Two arms: activity treatment and control
B Intervention duration: Minimum 3 months
 Sample
B Size: based on effect size estimate for primary
endpoint
- Starting point for planning: N Z 100 (50 per arm)
B Recruitment: through clinical settings (rather than
media)
B Inclusion criteria: disease severity (range to minimize
variability); activity level (sedentary to light or
moderate activity levels during run-in)
 Intervention Group
B General framework:
- Based on a theoretical model of health behavior
- Activity program with individualized motivational
components
- Education component to enhance understanding
the activity/exercise components and increase
confidence/self-efficacy; may include written,
tailored materials
Table 5 Key features of COPD trials by effect on physical activity (PA).
Study characteristic Frequency of studies
showing improvement in
PA
(N Z 5)
Frequency of studies not
showing improvement in
PA
(N Z 3)
Based on theoretical model 3 60% 1 33%
Design
Randomized control trial 5 100% 2 66%
2 treatment arms 5 100% 3 100%
Recruitment through clinical settings 4b 80% 2 66%
Sample inclusion criteria
Disease severity 3 60% 3 100%
Activity level 0 0% 1 33%
Exercise alone or group
Alone 4 80% 2 66%
Both (alone and in group) 1 20% 1 33%
Setting
Facility 1 20% 1 33%
Home 2 40% 0 0%
Mixed (facility and home) 2 40% 2 66%
Active treatment intervention
Exercise
Type:
Walking 4 80% 2 66%
Durationa:
30e45 min per session 3 60% 2 66%
Frequencya:
3 times/week 4 80% 2 66%
Behavioral intervention
Individualized training 3 60% 1 33%
Counseling-general or motivational 2 40% 0 0%
Education-program or print 4 80% 1 33%
Contact-personal 3 60% 1 33%
Social support 0 0% 1 33%
Contact-print 0 0% 0 0%
Sample size
50 2 40% 3 100%
50e160 3 60% 0 0%
Trial duration
2 months 0 0% 1 33%
3 months 2 40% 0 0%
6e12 months 3 60% 2 66%
Outcomes and quality rating
Significant effect on PA 5 100% 0 0%
Significant effect on physical capacity 2 40% 2 66%
Quality rating, mean 29 e 31 e
Outcomes assessed
Physical activity
Electronic activity log (cell phone) 1 20% 1 33%
Pedometer 3 60% 1 33%
Actigraph 1 20% 0 0%
PA-exercise recorded on cell phoneb 1 20% 0 0%
CHAMPS Questionnaire 0 0% 1 33%
Voorrips Questionnaire 0 0% 1 33%
(continued on next page)
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Table 5 (continued )
Study characteristic Frequency of studies
showing improvement in
PA
(N Z 5)
Frequency of studies not
showing improvement in
PA
(N Z 3)
Physical capacity
6MWT 3 60% 3 100%
Shuttle walk test 2 40%
Ergonomic bike 3 60% 1 33%
Treadmill 1 20% 1 33%
6MWTZ 6 Minute Walk Test; CHAMPSZ Community Health Activities Model Program for Seniors; COPDZ chronic obstructive pulmonary
disease; PA Z Physical Activity.
a Frequency or duration not reported for remainder of studies.
b Patients performed and recorded daily exercise, walking at a tempo of music delivered via cell phone.
Designing activity trials for COPD 479B Activity intervention and individualized choices:
- Group or individual (participant choice)
- Setting: facility or home (participant choice)
- Walking program: 30 min, 3e5 times a week
 Gym, treadmill, with or without Nordic, music,
other individualized walking interventiondmatch
to setting and participant interests/individualized
program
 Initially: 2-week training/coaching sessions, 3
times a week to learn techniques and gain con-
fidence d in a facility setting
 Continued group or home training (participant
choice)
- Self-monitoring adherence program: activity log
and/or self-step monitoring
 Step-up/step-out program: steps per day
(pedometer)
- Individualized social support encouragement
program
 Calls, phone, text messages, family or friend
partnership program
 Control Group
B Minimal intervention: recommend usual activities or
standard of care for exercise; may provide print
materials but no training, motivational counseling, or
encouragement follow-up
 Outcomes
B Primary (PA):
- Activity: e.g., activity monitor (time spent seden-
tary) or pedometer (steps per day)
B Secondary:
- Patient-report of functional performance: e.g., SF-
36 PF or FPI-SF
- Physical capacity: e.g., 6MWD, shuttle walk test,
or cycle ergometer
- Breathlessness (Borg) per distance walked
B Exploratory:
- Health status: e.g., SGRQ total, SF-36 PCS and MCS
- Daily activity log: reported frequency, duration of
exercise
In conclusion, this review provided insight into the range
of study design, interventions, and outcome measures usedin studies examining the effects of behavioral intervention
on activity-related outcomes in chronic disease. Results
suggest these interventions can improve PA levels and point
to areas in need of greater clarity and precision to improve
this area of research.
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